ANALYTICAL AND LABORATORY EQUIPMENT 37
Microsphere formulation process scale-up
Camille Flores looks at technology that is changing the microsphere drug formulation process for the global pharmaceutical industry.
D
rug manufacturers have used the commonly known
method of sieving to classify the microspheres, facing difficulties with mesh blocking, lengthy drying and challenging SIP. Te Microsphere Refiner technology was launched combining filtration, cake washing, classification and drying, all in one step, with sterile product recovery.
Microsphere particles work as miniature time release capsules made of biodegradable polymer and carrying the API of parental drugs. Microspheres are small spherical particles, typically from 5µm up to 150µm.
Microspheres are created from various micro encapsulation processes (single or double emulsion, droplet formation…). At the end of this upstream stage, microspheres of random sizes are suspended in a large volume of liquid which needs to be processed. Te downstream stage consists in the microspheres being classified by size, over and under size particles need to be removed to obtain the micron size range desired. Te control of particle size distribution is critical during the formulation as it affects the time release effect of the micro capsules once injected in the patient’s body. Te microspheres are then washed, filtered and dried to be recovered in a sterile manner.
Fig 2. Example of microsphere particles size distribution.
To perform the downstream stage, the Microsphere Scalping and Refiner have been designed and developed with steam- in-place and full drainability capabilities, and are both tiltable to accommodate a sterile discharge.
www.scientistlive.com
Some processes require a first scalping pre-filtration step in order to remove and recover all the oversized microspheres. Ten with the Microsphere Refiner undersize particles are eliminated and the final product is washed, filtered, dried and recovered while maintaining the sterility envelope.
Traditionally sieving operation is achieved on non-sterile laboratory scale for microsphere drugs. But when sterile large scale production is needed, manufacturers are facing issues with blockage, sterility and poor product recovery.
Process scale up from R&D to industrial production is a common conundrum in the industry; therefore similar Microsphere Scalping and Refiner technologies have been used to perform the same method from lab to large scale manufacturing.
Small scale feasibility tests can
Fig 1. Scale-up Microsphere Refiner solutions.
also be carried out with small scale glass filter dryers (GFD) to filtrate and dry up to 50grams of cake, followed by the R&D Microsphere Scalping and Refiner classifying and drying up to 2kgs with sterile discharge. Ten industrial formulation of microspheres is performed using advanced sterile filter dryer technology.
For more information ✔ at
www.scientistlive.com/eurolab
Camille Flores is Business Development Manager, Powder Systems Limited (PSL), Liverpool, UK.
www.powdersystems.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68